Medicaid Report: April 2013
Shift from Fee-for-Service to Managed Medicaid: What is the Impact on Patient Care? An Early Review of Prescription Drug Utilization
Responsible Use of Medicines Report - October 2012
Featured Insight
Murray Aitken, Executive Director of the IMS Institute for Healthcare Informatics, discusses key findings from the new IMS Institute report Declining Medicine Use and Costs: For Better or Worse? Listen to his commentary.
Register here for the full IMS Institute report or access the NEW APP VERSION for iPads in iTunes.
Click here for additional featured insights.
About the IMS Institute for Healthcare Informatics
The IMS Institute for Healthcare Informatics leverages collaborative relationships in the public and private sectors to strengthen the vital role of information in advancing healthcare globally.
With access to IMS Health's extensive global data assets, analytics and expertise, the Institute is focused on objective, relevant insights and research that accelerate understanding and innovation critical to sound decision making and improved patient care.
Working with government agencies, academic institutions, the life sciences industry and payers, the Institute has a focused research agenda:
- Enhancing the use of information by healthcare stakeholders
- Optimizing the performance of medical care
- Understanding the future global role for biopharmaceuticals
- Supporting the role of innovation in health system products, processes and delivery systems
- Informing and advancing healthcare agendas in developing nations
Applying Research
 Biopharma Insights |
|
 Health Outcomes Insights |
|
 Health Services Research Network |
NEW: 2012 U.S. Medicines Report
Declining Medicine Use and Costs: For Better or Worse?
New White Paper
"Electronic Prescribing: Prevalence Within the Cholesterol Lowering Market." This report examines the current extent and intensity of retail
e-prescribing.
